Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

MicroPulse Laser Therapy in the Management of DME

  Channels: Retina | Posted 8/23/2016

Moderator Allen C. Ho, MD, leads panelists Robert L. Avery, MD; Lawrence S. Morse, MD, PhD; and Elias Reichel, MD, on a discussion of the role of MicroPulse laser therapy in the era of injections for the treatment of patients with diabetic macular edema (DME), and other macular conditions associated with edema and fluid (eg, chronic central serous retinopathy and retinal vein occlusion-associated macular edema). Despite the growing use of anti-VEGF therapy, there remains an unmet need in the treatment of these conditions and laser is still a relevant option.

Micropulse Laser

1 / 1 Series: Iridex Micropulse Webinar 2016


Allen C. Ho, MD
Professor of Ophthalmology, Thomas Jefferson University Attending surgeon Wills Eye Hospital
Mid-Atlantic Retina
Philadelphia, PA


Robert L. Avery, MD
Founder, CEO
California Retina Consultants and Research Foundation
Santa Barbara, CA

Lawrence S. Morse, MD, PhD
Professor of Ophthalmology, Director of Retina Services Department of Ophthalmology & Vision Science University of California-Davis
Sacramento, CA

Elias Reichel, MD
Professor and Vice Chair Director, Vitreoretinal Service Tufts-New England Eye Center
Boston, MA

68-year-old male with non-insulin-dependent diabetes mellitus

Pre MicroPulse: BCVA 20/50

18 months post 2 MicroPulse treatments
BCVA 20/40

Images courtesy of Dr. Elias Reichel